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The use of home health care (HHC) ser-
vices among Medicare end stage renal dis-
ease (ESRD) enrollees remains an under-
studied area.  In this article, the authors
report sociodemographic characteristics
and patterns of HHC utilization by
Medicare-covered ESRD patients.  The
authors found that those who were female,
age 85 or over, diabetic, and residing in the
New England or West South Central census
divisions were more likely to use HHC ser-
vices and were also more intensive users.
Analysis of use patterns in such high-risk
populations is necessary to ensure that
health policy changes do not have unin-
tended consequences for vulnerable
patients.  
INTRODUCTION
Over the past decade, Medicare spend-
ing on HHC has expanded faster than any
other expenditure component.  From 1990
to 1995, Medicare home health costs grew
more than 30 percent per year (Health
Care Financing Administration, 1996).
Much of this growth is the result of a liber-
alization and standardization of coverage
that occurred in the late 1980s (Welch,
Wennberg, and Welch, 1996).  As a result,
the number of home health agencies
increased by more than 50 percent from
1989 to 1995 (Welch, Wennberg, and
Welch, 1996).  Patterns of use among the
aged have been well documented.
However, the impact of this rapidly expand-
ing HHC industry on vulnerable patient
populations is still an understudied area.
This study uses a national claims-based
data set to examine HHC use by a special
group of Medicare beneficiaries, ESRD
patients.  The results from the analysis are
compared with the existing literature on
HHC use by Medicare beneficiaries over-
all.  The implications of recent changes to
the HHC benefit resulting from the
Balanced Budget Act of 1997 (BBA) are
also discussed.
ESRD PROGRAM 
Since its inception in 1973, Medicare’s
ESRD program has provided full Medicare
Parts A and B coverage to most individuals
diagnosed with ESRD, including most of the
cost of dialysis treatment and renal trans-
plantation.  Certain prescription medica-
tions are also covered, mainly, erythropoi-
etin for the anemia of renal failure and
immunosuppressant drugs (for a period of 3
years following transplantation).  Eligibility
for the ESRD program is based on con-
firmed diagnosis of the disease, regardless
of the patient’s age.  This is an important
distinction between elderly Medicare bene-
ficiaries and those in the ESRD program.
The distribution of sex and race among
ESRD beneficiaries is much less skewed
than for Medicare enrollees overall, proba-
bly due in large part to the younger age of
the group, on average. 
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Because of the chronic and debilitating
nature of the disease, ESRD patients are
much more costly than their elderly
Medicare counterparts.  The high cost
associated with the treatment of kidney
failure—either kidney transplantation or
life-long dialysis—represents a potentially
catastrophic cost to patients and their fam-
ilies.  ESRD patients were included in the
Medicare program to preserve their treat-
ment options and prevent the devastating
financial effects of the disease. 
In 1997, Medicare covered approximate-
ly 75 percent of total ESRD costs, estimated
at $15.64 billion (United States Renal Data
System, 1999).  Medicare spending per
patient-year during the period 1993-97 was
$43,000.  Program expenses vary by dialy-
sis modality and underlying disease state.
ESRD patients receiving hemodialysis, the
vast majority of program enrollees, cost
Medicare an average of $52,000 per patient-
year during this time period, $7,000 more
per patient-year than patients on peritoneal
dialysis and $35,000 more per patient-year
than those who had received transplants
(United States Renal Data System, 1999).
Across modalities and age groups, diabetic
ESRD patients represent the greatest pro-
portion of ESRD enrollees and the greatest
cost per patient-year.  On average, diabetic
patients (one-third of ESRD enrollees) cost
about $51,000 per patient-year for the peri-
od 1993-97, compared with $39,000 per
patient-year for non-diabetic patients
(United States Renal Data System, 1999).
Thus, high-risk subgroups exist in this pop-
ulation that is already much more costly
than other Medicare beneficiaries.
Both the cost and the incidence of ESRD
have been increasing over the past decade,
with ESRD beneficiaries generating more
than seven times the expenditures of aged
Medicare beneficiaries (Health Care
Financing Administration, 1996).   Even
though the ESRD program remains a small
percentage of total Medicare spending at
5.6 percent, policymakers have been
increasingly concerned about cost contain-
ment and quality of care for this popula-
tion.  Reimbursement and coverage deci-
sions made on the basis of existing litera-
ture may have serious consequences for
this group if its patterns of use differ from
those of Medicare enrollees overall.  Thus,
it is important to examine utilization for
this distinct patient population. 
HOME HEALTH CARE
HHC was originally used by hospitals in
response to the prospective payment sys-
tem as a way to shorten lengths of stay.
Following hospitalization, patients were
discharged earlier and received home
health services in lieu of increased inpa-
tient days.  Research in this area has docu-
mented the impact of HHC in reducing
hospital days and costs (Hughes et al.,
1997; Feldman, Latimer, and Davidson,
1996).  Prior to 1980, Medicare coverage of
HHC was contingent upon prior hospital-
ization (Welch, Wennberg, and Welch,
1996).  This requirement was eliminated in
1980, and subsequent changes to Medicare
further expanded the scope of coverage.
In 1994, nearly 8 percent of Medicare ben-
eficiaries used HHC; the average number
of visits per user increased from 52 visits in
1992 to 65 in 1994 (Mauser, 1997).  The dis-
tribution of visits is highly skewed, with 14
percent of users receiving more than 150
visits yearly (Mauser, 1997).
Mauser and Miller (1994) report that
many of the same variables that predict
number of home health visits are also pre-
dictive of the probability of using HHC.
These variables include age, race, sex,
marital status, number of activities of daily
living and instrumental activities of daily
living, and supply variables.  These
authors’ logistic regression analysis indi-
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cates that the probability of any HHC use is
higher for persons of races other than
white and females, and increases with age
of the patient and the number of medical
conditions that a beneficiary has ever had
(Mauser and Miller, 1994).
Several authors have documented
growth and geographic variation in HHC
services and expenditures for elderly
Medicare beneficiaries.  Bishop and
Skwara (1993) report a wide range of per-
sons served per 1,000 enrollees and visits
per person served across the Nation.
Overall, the New England, Middle Atlantic,
and East South Central areas had the
largest proportion of persons served (78.6
to 93.9 persons per 1,000 enrollees, com-
pared with a U.S. average of 64.8).
However, these areas did not always have
the highest number of visits per person
served.  Though the correlation may not
be perfect, there does exist a great deal of
geographic variation in the use of HHC
among the elderly, regardless of the unit of
analysis.  These findings are generally con-
sistent with those reported elsewhere, but
a few disparities do exist (Welch,
Wennberg, and Welch, 1996; Kenny and
Dubay, 1992).  These may be partly a func-
tion of the different time periods and units
of analysis reported by these articles.
COMPARISON OF ESRD AND
MEDICARE BENEFICIARIES
Table 1 provides a comparison of the
demographic characteristics and geo-
graphic distribution of Medicare and
ESRD beneficiaries.  Comparisons of
demographic characteristics show that, rel-
ative to Medicare beneficiaries, ESRD ben-
eficiaries are younger, have a higher pro-
portion of males, and a significantly higher
proportion of black persons.  Because the
average ESRD beneficiary is younger than
the average Medicare enrollee, HHC use
may be lower for ESRD patients after con-
trolling for age and other characteristics.
However, ESRD patients, because of the
nature of their disease, may be sicker than
their Medicare peers and therefore, con-
sume a greater amount of all health care
services, including HHC.
Table 2 shows the distribution of HHC
use (persons served) among the Medicare
and ESRD populations across sex, age, race,
and geographic region.  This table shows
that, for Medicare beneficiaries overall,
HHC is most often used by those patients
who are white, age 75-84 years, and female.
These figures can be misleading, however,
because they fail to consider the underlying
distribution of patients across these cate-
gories.  Table 3 shows, for the same charac-
teristics as in Table 2, the number of
Medicare and ESRD home health users per
1,000 program enrollees.  These figures
reveal great differences in the numbers of
HHC users between the Medicare popula-
tion overall and the ESRD subgroup.  Per
1,000 program enrollees, there were 276
HHC users in the ESRD program in 1995,
compared with 103 in the total Medicare pro-
gram.  That is, compared with average
Medicare enrollees, ESRD beneficiaries
were on average more than twice as likely to
use HHC services.  Proportionately, the use
of HHC is concentrated among those who
are in the oldest age category (85 and over),
white, and female.  
Tables 2 and 3 also show the most recent
data available on the distribution of HHC
among Medicare beneficiaries (including
the disabled).  These figures confirm that
HHC use is relatively higher in the New
England, East South Central, and West
South Central census divisions, although
total use (in thousands of persons served) is
highest in the South Atlantic census division
(Health Care Financing Administration,
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1997).  These geographic variations, howev-
er, have not been explained by differences
in demographic variables such as age, sex,
and race (Mauser and Miller, 1994). 
Prior to the BBA, home health agencies
were reimbursed on a reasonable-cost
basis.  Thus, agencies would be able to
pass the high cost of more intensive care
services on to Medicare (i.e., higher
charges would indicate more intense home
care).  This analysis assumes that total
charges and/or paid claim amounts are
indicative of resource intensity.  Table 4
summarizes the resource utilization inten-
sity of home health services provided to
ESRD versus Medicare beneficiaries.
Charges for HHC were $6,045 per person
served for Medicare beneficiaries in 1995
and $6,726 per person served for patients
enrolled in the ESRD program in the same
year.  This difference is smaller when com-
paring average program payments per per-
son served ($4,441 for Medicare versus
$4,696 for the ESRD program). 
The disparities between home health
charges and program payments for the two
programs are larger when the comparison
is made per enrollee (as opposed to HHC
users).  This is the result of the combina-
tion of more intense HHC utilization and a
higher proportion of ESRD enrollees using
home health services compared with
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Table 1
Demographic Characteristics and Geographic Distribution of Medicare and ESRD Beneficiaries:
United States, 1995
Medicare1 ESRD Beneficiaries
Number in Number in
Characteristic Thousands Percent Thousands Percent
Total 37,566 100.0 257 100.0
Age
Under 65 Years 4,409 11.7 152 59.1
65-74 Years 18,291 48.7 66 25.7
75-84 Years 11,031 29.4 35 13.6
85 Years or Over 3,835 10.2 5 1.9
Sex
Male 16,071 42.8 139 54.1
Female 21,495 57.2 118 45.9
Race
White 32,240 85.8 147 57.2
Black 3,350 8.9 79 30.7
Other 1,568 4.2 29 11.3
Census Division
New England 2,046 5.4 11 4.4
Middle Atlantic 5,866 15.6 37 14.7
East North Central 6,211 16.5 40 15.7
West North Central 2,782 7.4 15 5.8
South Atlantic 6,951 18.5 54 20.9
East South Central 2,400 6.4 19 7.2
West South Central 3,569 9.5 29 11.4
Mountain 1,959 5.2 11 4.4
Pacific 5,004 13.3 36 13.9
Primary Disease Leading to ESRD
Diabetes NA — 87 33.7
Hypertension NA — 72 28.0
Glomerulonephritis NA — 39 15.0
Other Disease NA — 60 23.3
1 These numbers include both aged and disabled Medicare beneficiaries and do not include beneficiaries enrolled in managed care plans.
NOTES: ESRD is end stage renal disease.  NA is not available.  Percentages may not sum to 100.0 because of rounding.
SOURCE: (Health Care Financing Administration, 1997.)
Medicare beneficiaries overall.  As shown
in Table 4, average annual charges per
enrollee were $1,781 for the ESRD program
and $616 for Medicare in 1995.  The higher
charges reported in Table 4 imply that
ESRD beneficiaries, on average, had more
home health visits and/or that they con-
sumed more resources during each visit.  
METHODS
Data
This study uses detailed patient demo-
graphic and claims data extracted from the
USRDS for calendar year 1995 to examine
the characteristics of HHC users and geo-
graphic variation in HHC use among ESRD
beneficiaries.  The USRDS is a national
data system that collects, analyzes, and dis-
tributes information on the incidence,
prevalence, treatment, morbidity, and mor-
tality of ESRD in the United States (Held et
al., 1997).  The data consist of several files
containing clinical, demographic, and
claims information for most ESRD patients.
Because the USRDS collects data on most
persons diagnosed with ESRD, it is possible
to conduct much more detailed analyses on
this population than would be the case with
other sources of Medicare data, such as the
Current Beneficiary Survey.
The main source of data in the USRDS
data base is derived from HCFA sources,
including the Medicare enrollment data-
base and ESRD program management and
medical information system databases.
The USRDS also receives data on non-
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Table 2
Demographic Characteristics and Geographic Distribution of Users Among All Medicare and
ESRD Beneficiaries Served: United States, 1995
Medicare1 ESRD Beneficiaries
Number in Number in
Characteristic Thousands Percent Thousands Percent
Total 3,430 100.0 71 100.0
Age
Under 65 Years 262 7.6 25 35.7
65-74 Years 946 27.6 23 32.1
75-84 Years 1,408 41.0 19 26.3
85 Years or Over 855 24.9 4 5.8
Sex
Male 1,222 35.7 33 45.8
Female 2,247 65.5 39 54.2
Race
White 2,935 85.5 46 64.7
Black NA NA 22 31.3
Other 2534 215.6 3 4.0
Census Division
New England 245 7.1 4 6.3
Middle Atlantic 518 15.1 11 15.8
East North Central 543 15.8 12 16.3
West North Central 223 6.5 4 5.3
South Atlantic 682 19.9 14 20.1
East South Central 306 8.9 5 7.0
West South Central 430 12.5 9 13.3
Mountain 141 4.1 2 3.5
Pacific 341 9.9 8 11.9
1 Utilization rates do not reflect Medicare enrollees in managed care plans.
2 Figures include all persons of unknown race or race other than white.
NOTES: ESRD is end stage renal disease.  NA is not available.  Percentages may not sum to 100.0 because of rounding.
SOURCE: (Health Care Financing Administration, 1997.)
Medicare ESRD patients through dialysis
facilities, special surveys that the USRDS
conducts in conjunction with HCFA, the
Department of Veterans Affairs (since
1990), and other sources.  Thus, the USRDS
contains some information on virtually
every person with ESRD in the United
States.  HCFA provides paid claims infor-
mation for ESRD program enrollees (about
93 percent of all ESRD patients), and dialy-
sis facilities and ESRD networks provide
some cost and charge information for non-
Medicare enrollees.  Recently, the USRDS
also coordinated with the United Network
for Organ Sharing (UNOS) to include infor-
mation on kidney transplantation (United
States Renal Data System, 1999).
Statistical Analysis
To identify factors that are more likely to
be associated with HHC utilization among
ESRD beneficiaries, we convert the USRDS
data from claims-level into patient-level data
and use a logistic regression model to esti-
mate the probability of service utilization.
The model to be estimated is:
Pilogit(Pi)=ln( l - Pi )
=β0+β1Xi1+...+βkXik+εi(1)
Pi in equation (1) is the probability of
having at least one home health visit in the
study period for the ith ESRD beneficiary.
The explanatory variables, Xi1, ...,Xik,
include age, race, sex, primary disease
leading to ESRD, dialysis modality, dialysis
history, and geographic region.  Age vari-
ables are categorized into four groups:
under 65, 65-74, 75-84, and 85 years or over,
with the last group serving as the refer-
ence group.  The race variable is broken
down into three categories: white, black,
and other race.  The reference group is all
other races.  Primary disease leading to
ESRD is operationalized as a dummy vari-
able indicating either diabetes, hyperten-
sion, glomerulonephritis, or other disease,
with the diabetes category as the reference
group (Table 5).  Dialysis modality is clas-
sified as center hemodialysis, home
hemodialysis, peritoneal dialysis (includ-
ing continuous ambulatory peritoneal dial-
ysis, continuous cyclic peritoneal dialysis,
and other peritoneal dialysis), and trans-
plantation, using home hemodialysis as the
reference group.  Patients who switched
modalities are combined into a single cate-
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Table 3
Demographic and Geographic Characteristics
of Home Health Care Users Among All
Medicare and ESRD Beneficiaries Served:
United States, 1995
Characteristic Medicare1 ESRD
Per 1,000 Enrollees
Total 103 76
Age
Under 65 Years 62 167
65-74 Years 58 346
75-84 Years 142 534
85 Years and Over 241 722
Sex
Male 84 234
Female 115 326
Race
White 100 312
Black NA 282
Other 2110 98
Census Division
New England 127 399
Middle Atlantic 94 296
East North Central 90 286
West North Central 86 256
South Atlantic 106 266
East South Central 129 268
West South Central 127 323
Mountain 88 217
Pacific 99 238
1 Utilization rates do not reflect Medicare enrollees in managed 
care plans.
2 Figures include all persons of unknown race or race other than white.
NOTES: ESRD is end stage renal disease. NA is not available. These
figures were generated by combining results from the United States
Renal Data System data with figures from the Health Care Financing
Administration.  Because the latter gives a smaller number of ESRD
beneficiaries, the figures shown are slightly overestimated.
SOURCE: (Health Care Financing Administration, 1997.)
gory.  History of dialysis is categorized as
less than 1 year, 1-3 years, and more than 3
years.  Equation (1) selects “less than 1
year” as the reference group.  Geographic
area is classified by dummy variables for
the nine census divisions listed in Tables 1-
3, with the New England division as the ref-
erence group.
To examine resource utilization intensity
across various subgroups among those
ESRD beneficiaries who used HHC ser-
vices, a log-linear model is estimated:
log(Yj)-β0+β1Xj1+...+βkXjk+εj (2)
Yj is the annual home health charges for
the jth home health service user.  The
explanatory variables are identical to
those in equation (1).  Because of the
skewed distribution of home health ser-
vice charges, the dependent variable was
specified as the logarithm transformation
of charges (Kennedy, 1998).
RESULTS
Results for the estimation of equation (1)
are given in Table 6 and closely reflect the
proportional figures listed in Table 3.
These suggest that ESRD beneficiaries
who received HHC at least once during the
study period are somewhat similar to
Medicare home health users, but with
some important differences.  ESRD
patients with the following characteristics
are more likely to use home health ser-
vices: 85 years or over, female, white,
switched dialysis modalities during the
study period, and diabetes as the primary
disease leading to ESRD.  Unlike what has
been observed for Medicare enrollees
overall, ESRD beneficiaries who are not
white are less likely to use home health
services, although the difference for black
persons is small.  Within the ESRD popula-
tion, HHC has the highest utilization rate
among medically vulnerable patient
groups; those patients for whom diabetes
was the leading cause of ESRD were more
likely to use HHC.  
The results for dialysis history are espe-
cially intriguing.  Patients in the reference
group (less than 1 year of dialysis) were
the least likely among the three groups to
use HHC.  However, the probability of use
appears to peak in the mid-range of dialysis
history (1-3 years), with use among those
patients with a longer history of dialysis
nearly equal to newer dialysis patients.  If it
is reasonable to expect that sicker patients
use more HHC services, which is implied
by the differences in use between
Medicare and ESRD beneficiaries on aver-
age, then this pattern would seem to indi-
cate that patients in the middle range of
dialysis history are relatively sicker than
patients with shorter or longer dialysis his-
tories.  This could happen if healthier
patients were expected to have received a
transplant by that time, eliminating them
from the 1-3-year history group.  One
would expect patients with a long dialysis
history to be relatively sicker.  However, it
could be the case that those in the longer
history group, having survived on dialysis
for an extended period of time, may also be
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Table 4
Charges and Payments for Home Health Care
Users Among All Medicare and ESRD
Beneficiaries Served: United States, 1995
Charges and Payments Medicare1 ESRD
Total in Thousands
Charges $21,591,139 $502,204
Program Payment 15,391,094 350,656
Per Person Served
Charges 6,045 6,726
Program Payment 4,441 4,696
Per Enrollee
Charges 616 1,781
Program Payment 452 1,243
1 Utilization rates do not reflect Medicare enrollees in managed care
plans.
NOTE: ESRD is end stage renal disease.
SOURCES: (Health Care Financing Administration, 1997; United
States Renal Data System, 1999.)  Data analysis by the authors.
a relatively healthy group.  The coefficient
for long dialysis history was not significant,
however.  Patients who had received trans-
plants were slightly less likely than others
to use HHC.  The relationship between
dialysis history, survival, and health is an
important area for future research.
Geographic patterns of use were very sim-
ilar to previous results for the entire
Medicare population.  Residence in the New
England area significantly increased the
probability of HHC use for this population,
with the West South Central division also
exhibiting relatively high use, even after con-
trolling for the other variables in the model.  
Table 7 gives the results for the estima-
tion of equation (2).  Among ESRD benefi-
ciaries who use HHC, service intensity was
lower for white persons than black persons,
even though black persons are less likely to
use HHC.  Thus, although fewer black peo-
ple use HHC, those that do use relatively
more of these services than white people.
Females, diabetic persons, and persons 85
years of age or over were more likely to use
HHC and also tended to be more intensive
users.  Home and center hemodialysis
patients were also more intensive users of
HHC, relative to other modalities.
Interestingly, patients with a history of 1 to
3  years of dialysis had lower HHC charges
than patients with longer or shorter histo-
ries, despite the fact that these patients
were most likely to use HHC.
DISCUSSION
Because of the unique composition of
the USRDS data, the use of HHC among
ESRD beneficiaries can be examined in
much more detail than has typically been
available for aged Medicare beneficiaries.
In particular, the availability of clinical
information makes it possible to better con-
trol for patient-specific characteristics,
such as primary disease leading to ESRD
(a marker for medical risk).  However,
some socioeconomic variables that have
been shown by others to be significant,
such as marital status and number of activ-
ities of daily living, are unavailable from
this data source.  The latter may be a par-
ticularly important missing variable given
that several previous studies have docu-
mented a strong association between func-
tional status and HHC use (Mauser and
134 HEALTH CARE FINANCING REVIEW/Summer 1999/Volume 20, Number 4
Table 5
Percent of ESRD Patients with Selected Non-Demographic Characteristics: United States, 1995
Variable Home Health Care Users Non-Home Health Care Users
Percent
Primary Disease Leading to ESRD
Diabetes 45.5 29.5
Hypertension 27.6 28.2
Glomerulonephritis 8.8 17.2
Other 18.1 25.1
Dialysis History 1 
Less than 1 Year 4.7 3.8
1-3 Years 57.8 47.0
More than 3 Years 37.5 49.2
Dialysis Modality
Center Hemodialysis 72.6 63.2
Home Hemodialysis 3.5 2.7
Peritoneal Dialysis 7.9 9.2
Transplant 7.4 17.8
Switched Dialysis Modality 8.6 7.1
1 Average dialysis history for Home Health Care users is 3.71 years; average for non-Home Health Care users is 4.8 years.
NOTE:  ESRD is end stage renal disease.
SOURCES: (United States Renal Data System, 1999.)  Data analysis by the authors.
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Miller, 1994; Hing and Bloom, 1990;
Branch et al., 1988; Soldo, 1985; Evashwick
et al., 1984).  To the extent that these fac-
tors influence the use of HHC by ESRD
patients, the results presented in this arti-
cle may be biased. 
This empirical analysis does not include
supply-side factors that may affect the use
of HHC.  Several studies have shown that
factors such as number of nursing home
beds or Medicare-certified home health
agencies in an area influence the number
of HHC visits per user and the number of
users per 1,000 enrollees (Swan and
Benjamin, 1990; Kenney and Dubay, 1992;
Kenney, 1993).  Those studies that have
found a significant impact on use typically
have relied on data from earlier time peri-
ods and did not examine resource intensity.
Some of these effects are substantial, but
they still do not fully explain other aspects
of use of interest here, such as geographic
variation.  The most recent available study,
which uses data from the 1992 Medicare
Current Beneficiary Survey, failed to show
an impact of supply-side variables on the
number of visits or reimbursement, nor
were these variables able to explain geo-
Table 6
Logistic Regression Results for Home Health Care Use Among ESRD Beneficiaries: 
United States, 1995
Parameter Odds
Variable Estimate Ratio p-Value
Intercept 0.73 NA NA
Sex
Male -0.29 0.75 0.0001
Age
Under 65 Years -1.24 0.29 0.0001
65-74 Years -0.59 0.56 0.0001
75-84 Years -0.22 0.81 0.0001
Race
Black -0.06 0.94 0.0001
Other Race -0.33 0.72 0.0001
Disease Leading to ESRD
Hypertension -0.62 0.54 0.0001
Glomerulonephritis -0.95 0.39 0.0001
Other -0.73 0.48 0.0001
Dialysis Modality
Center Hemodialysis 0.05 1.05 0.0115
Peritoneal Dialysis -0.07 0.93 0.0039
Transplant -0.36 0.70 0.0001
Switch Dialysis Modality 0.50 1.65 0.0001
Dialysis History
1-3 Years 0.16 1.17 0.0001
More than 3 Years 0.02 1.02 0.4323
Census Division
Middle Atlantic -0.47 0.63 0.0001
East North Central -0.50 0.61 0.0001
West North Central -0.65 0.52 0.0001
South Atlantic -0.40 0.67 0.0001
East South Central -0.42 0.66 0.0001
West South Central -0.27 0.76 0.0001
Mountain -0.75 0.47 0.0001
Pacific -0.55 0.58 0.0001
NOTES: ESRD is end stage renal disease.  NA is not applicable. N = 268,650; log likelihood: 21583.26 with 20 degrees of freedom (p = 0.0001).
SOURCES: (United States Renal Data System, 1999.)  Data analysis by the authors.
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graphic variation (Mauser and Miller,
1994).  Because recent research has intro-
duced some inconsistency into the effect of
supply-side factors as explanatory variables
for the use of and geographic variation in
HHC and because usable data sources
were unavailable to the authors, these were
not included as part of this study.  Clearly,
though, the impact of supply-side forces on
use and geographic variation is an impor-
tant area for future research. 
It is difficult to conclude whether ESRD
beneficiaries who use HHC are a high-risk
group overall because many of the most
intense users of HHC also seem to have
the most access to those services.
However, there are two groups that tended
to use fewer but more intense HHC ser-
vices.  These groups may be especially vul-
nerable to changes in the home health ben-
efit.  The estimated coefficients for race
indicate that black persons are slightly less
likely to use HHC, but those that do are
more intensive users.  The results for dial-
ysis history follow a similar pattern.
Subsequent research in this area may
more completely characterize users of
HHC within these subgroups and ESRD
Table 7
Log (Charge) Regression Results for Home Health Care Users Among ESRD Beneficiaries:
United States, 1995
Parameter
Variable Estimate t-Value
Intercept 8.56 230.55
Sex
Male -0.16 -15.85
Age
Under 65 Years -0.33 -13.1
65-74 Years -0.18 -7.73
75-84 Years -0.10 -4.13
Race
Black 0.13 11.56
Other Race -0.02 -0.83
Disease Leading to ESRD
Hypertension -0.36 -28.34
Glomerulonephritis -0.53 -27.88
Other -0.41 -28.67
Dialysis Modality
Center Hemodialysis 0.03 1.37
Peritoneal Dialysis -0.01 -0.35
Transplant -0.06 -1.9
Switch Dialysis Modality -0.11 -3.82
Dialysis History
1-3 Years -0.11 -3.57
More than 3 Years -0.08 -2.64
Census Division
Middle Atlantic -0.17 -7.28
East North Central -0.17 -7.25
West North Central -0.28 -9.43
South Atlantic -0.09 -3.93
East South Central 0.07 2.44
West South Central 0.42 17.15
Mountain -0.07 -2.21
Pacific -0.11 -4.47
NOTES: ESRD is end stage renal disease.  N = 71,032; adjusted R 2 = 0.06.
SOURCES: (United States Renal Data System, 1999.)  Data analysis by the authors.
enrollees overall.  Because the most
recently reported data available from
HCFA or through the existing literature
fails to distinguish between the aged and
disabled populations within Medicare, it is
not possible to compare our results for the
ESRD population specifically to aged
Medicare beneficiaries.
High-risk groups within the ESRD pro-
gram include patient groups with limited
access to HHC (proxied as those who are
less likely to use HHC) and those who use
more intensive home care services (prox-
ied as those with the highest HHC costs).
These groups will be most affected by
changes in Medicare’s home health bene-
fit, but they may be affected differently.
Policies designed to provide incentives to
reduce the cost of providing home care,
but not necessarily limit the number of vis-
its, will affect intensive users of HHC
directly.  These policies could, in turn, have
an impact on the overall access to home
care if the inability to fully recover costs
results in fewer agencies.  
The BBA has two provisions that may
especially affect intensive users of home
care (Forster, 1998).  First, some HHC use
will be moved from Part A to Part B, which
usually has a higher amount of costsharing.
If black ESRD patients have fewer economic
resources than other groups, the copayment
requirement could further reduce their
access to HHC.  Second, payment for home
care will move to a prospective payment sys-
tem designed to provide home health agen-
cies with incentives to lower costs.  If those
incentives translate into an unwillingness to
serve more intense users of HHC, then
black ESRD patients may be at particular
risk.  Additionally, the BBA imposes per ben-
eficiary annual limits on agencies.  This limit
does not place a restriction on the number of
visits to individual patients, but it is designed
to prevent further increases in average uti-
lization per patient.  The limits are aggregat-
ed to allow a balancing of higher and lower
cost patients.  An agency that serves a large
proportion of ESRD patients, especially
black persons, may have difficulty balanc-
ing the more intense needs of these
patients with those of lower cost patients.
In that case, the agency might avoid serv-
ing these patients.
CONCLUSION
The figures presented here indicate that
likelihood of using HHC services is greater
among certain vulnerable subgroups of a
population that is already at higher risk
than the average Medicare beneficiary.  In
addition, certain groups of ESRD patients
tend to use significantly more intense HHC
services than other patients.  Any policy
pertaining to the use of HHC services will
likely have a larger effect on high-risk
groups within the ESRD program than for
the average ESRD patient.  Considering
that ESRD beneficiaries, on average, are
more than twice as likely to use HHC ser-
vices and use more HHC compared with
the average Medicare enrollee, the latter
effect may be even greater than what has
been shown to date for all Medicare
enrollees.  Also, although access to HHC
does not seem to be a problem for
Medicare patients overall, this may be an
issue for those with ESRD, especially
because black persons and diabetic per-
sons (intense users) comprise a significant
proportion of the ESRD population.  
Given these facts and to the extent that
the use of HHC may also influence patients’
choice of dialysis modality, care must be
taken in the design of cost-containment
strategies, particularly payment methodolo-
gies, that will apply to all Medicare benefi-
ciaries.  Decisionmakers should engage in
careful monitoring of ESRD patients and
high-risk subgroups after changes in HHC
or related policies to ensure that these 
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populations are not adversely affected.  In
addition, further research is necessary to
examine the use of HHC among ESRD ben-
eficiaries while addressing the limitations
already discussed.
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